Test interferences from endogenous antibodies

Journal of Clinical Ligand Assay

Volumn 20, Issue 2, 1997, Pages 180-189

  Levinson, Stanley S ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Competitive binding Idiotopes; HAMA; Heterophile antibodies; Rheumatoid factors; Two site immunometric assays

Indexed keywords

AMYLASE; ANTIBODY; AUTOANTIBODY; AUTOANTIGEN; CHIMERIC ANTIBODY; CREATINE KINASE; HETEROPHILE ANTIBODY; IMMUNOGLOBULIN F(AB) FRAGMENT; IMMUNOGLOBULIN IDIOTYPE; LACTATE DEHYDROGENASE; RHEUMATOID FACTOR;

BINDING COMPETITION; ENZYME ASSAY; HUMAN; IMMUNOASSAY; LABORATORY TEST; NONHUMAN; REVIEW; TECHNIQUE;

ANIMALIA;

EID: 0030846068     PISSN: 10811672     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (39)

1. Nahm MN, Hoffmann JW: Heteroantibody: Phantom of the Immunoassay. Clin Chem 1990;36:829.
2. Miller JJ, Levinson SS: Interferences in immunoassay. In Immunoassay. Ed. Diamandis EP and Christopoulos TK. Academic Press, Chapter 7, p. 165-187, 1996.
3. 2 monoclonal antibody to patients with ovarian cancer. J Nucl Med 1992;33:1958-1963.
4. Hansen HJ, Sullivan CL, Sharkey RM, et al: HAMA interference with murine monoclonal antibody-based immunoglobulins. J Clin Immunoassay 1993:16:294-299.
5. Prince AM, Brotman B, Jass D, et al: Specificity of the direct solid-phase radioimmunoassay for detection of hepatitis B antigen. Lancet 1973;i:1346-50.
6. Hunter WM, Budd PS: Circulating antibodies to ovine and bovine immunoglobulin in healthy subjects: a hazard of immunoassays. Lancet 1980;ii:1136.
7. Levinson SS: Antibody Multispecificity in Immunoassay Interference. Clin Biochem 1992;25:77-87.
8. Agnello V: Rheumatoid factor cross idiotypes. Springer Semin Immunopathol 1988;10:203-214.
9. Boscato LM, Stuart MC: Incidence and specificity of interference in two-site immunoassays. Clin Chem 1986;32:199-200.
10. Olds LC, Miller JJ: Anti-F(ab')2 antibodies that interfer with interpretation of the anti-C3 assay for immune complexes in children with rheumatic diseases. Arth Rheum 1984; 27:330-336.
11. Kunkel HG, Agnello V, Joslin F, et al: Cross idiotypic specificity among monoclonal IgM proteins with anti-gammaglobulin activity. J Exp Medllivan 1983;139:128-136.
12. Jerne, NK: The generative grammar of the immune system. Science 1985; 229:1057-1059.
13. Bose R, Ekramoddoullah AKM, Kisil FT, et al: Human and murine antibodies to Rye grass pollen allergen LolpIV share a common idiotope. Immunology 1988;63:579-84.
14. Ritter D, Stott R, Grant N, et al: Endogenous antibodies that interfere with thyroxine fluorescence polarization assay but not with radioimmunoassay or EMIT. Clin Chem 1993;39:508-511.
15. Phillips TM. High performance immunoaffinity chromatographic detection of immunoregulatory anti-idiotypic antibodies in cancer patients receiving immunotherapy. Clin Chem 1988;34:1689-1692.
16. Papoian R: Non-specific immunoglobulin interactions may lead to false-positive results in assays for human anti-mouse monoclonal antibodies (HAMA). J Immunoassay 1992;13:289-295.
17. HAMA Survey Group: Interlaboratory survey of methods for measuring human anti-mouse antibodies. Clin Chem 1992;38:172-3.
18. Kricka LJ, Nozaki O, Goodman DBP: Simple qualitative immunoassay of human anti-mouse antibodies evaluated. Clin Chem 1992;38:2558-2559.
19. Thompson RJ, Jackson AP, Langiois N: Circulating antibodies to mouse monoclonal immunoglobulins in normal subjects - Incidence, species specificity, and effects on a two-site assay for creatine kinase-MB isoenzyme. Clin Chem 1986;32;476-81.
20. Beinhaus G, Mössner E, Lenz E: Anti-interference for immunoassays with monoclonal antibodies. In Klapdor R. Ed. Recent results in tumor diagnosis and therapy. p. 469-71, Müchen:Zuckschwerde Velang, 1990.
21. Kricka LJ, Schmerfeld-Pruss D, Senior M, et al: Interference by human anti-mouse antibody in two-site immunoassays. Clin Chem 1990;36:892-894.
22. Reinsberg J: Different efficacy of various blocking reagents to elminate interferences by human antimouse antibodies with a two-site immunoassay. Clin Biochem 1996;29:148.
23. Lasson A, Sjöquist J: Chicken antibodies: a tool to avoid false positive results by rheumatoid factor in latex fixation tests. J Immunol Meth 1988;108:205-208.
24. Vaidya HC, Beatty BG: Eliminating interference from heterophilic antibodies in a two-site immunoassay for creatine kinase MB by using F(ab')2 conjugate and polyclonal mouse IgG. Clin Chem 1992;38:1737-42.
25. Kuroki M, Matsumoto Y, Arakawa F, et al. Reducing interference from heterophilic antibodies in a two-site immunoassay for carcinoembryonic antigen (CEA) by using a human/mouse chimeric antibody to CEA as the tracer. J Immunol Methods 1995;180:81-91.
26. Primus FJ, Kelley EA, Hansen HJ, et al: "Sandwich"-type of immunoassay of carcinoembryonic antigen in patients receiving murine monoclonal antibodies for diagnosis and therapy. Clin Chem 1988;34:261-264.
27. Müller W, Mierau R, Wohltmann D, et al: Interference of IgM rheumatoid factor with nephelometric C-reactive protein determinations. J Immunol Methods 1985; 80:77-90.
28. Becker W, Goldenberg DM, Wolf F: The use of monoclonal antibodies and antibody fragments in the imaging of infectious lesions. In Seminars in Nuclear Medicine 1994; XXIV Ed. Freeman LM, Blaufox, MD. pp 142-53.
29. Harwood SJ, Camblin JG, Hakki S, et al: Use of technetium antigranulocyte monoclonal antibody Fab' fragments for the detection of osteomyelitis. Cell Biophysics 1994;24-25:99-107.
30. Weiden PL, Wolf SB, Breitz HB, et al: Human anti-mouse antibody suppression with cyclosporin A. Cancer 1994;73(Suppl 3):1093-1097.
31. Kashmiri SV, Shu L, Padlan, et al: Generalization, characterization, and in vivo studies of humanized anticarcinoma antibody CC49. Hybridoma 1995;14:461-473.
32. Marks C, Marks JD: Phage libraries: A new route to clinically useful antibodies. N Engl J Med 1996335:730-733.
33. Remaley AT, Wilding P: Macroenzymes:biochemical characterization, clinical significance, and laboratory detection. Clin Chem 1989;32:2261-2270.
34. Miffin TE, Bruns DE: University of Virginia Case Conference-Macroamylase, Macro creatine kinase, and other macroenzymes. Clin Chem 1985;31:1743-1748.
35. Lott JA, Suman PT, Sawhnet AK, et al: Assays of serum Iipase:analytical and clinical considerations. Clin Chem 1986;32:1290-1302.
36. Wu AHB, Bowers Jr GN: Evaluation and comparison of immunoinhibition and immunoprecipitation methods for differentiating MB from BB and macro forms of creatine kinase isoenzymes in patients and healthy controls. Clin Chem 1982;28:2017-2021.
37. Trocha PJ: Lactate dehydrogenase isoenzymes linked to beta-lipoproteins and immunoglobulin A. Clin Chem 1977;23:1780-1783.
38. Nagamine M. Lactate dehydrogenase isoenzymes linked to immunoglobulin A in two cases. Clin Chim Acta 1972;36:139-144.
39. Markel SF, Janich SL: Complexing of lactate dehydrogenase isoenzyme with immunoglobulin A of the kappa class. Am J Clin Pathol 1974:61;328-332.